Lund, Sweden, 7 January 2025. Hansa Biopharma AB, “Hansa" or the "Company” (Nasdaq Stockholm: HNSA), today announced that management will attend the 43rd Annual J.P. Morgan Healthcare Conference. If you are interested in a meeting, please contact Hansa Biopharma at ir@hansabiopharma.com. The Company has achieved several key milestones in the …
